Skip to main content

What the FDA labels say about taking them together

Cinacalcet and etelcalcetide

Etelcalcetide's FDA label of March 8, 2026 names cinacalcet in its warnings and precautions section; the cinacalcet labels PlainMeds reads (2) do not name etelcalcetide. The etelcalcetide label: “Patients switching from cinacalcet to PARSABIV should discontinue cinacalcet for at least 7 days prior to initiating PARSABIV.”

Check it at the source: the cinacalcet FDA label on DailyMed (effective April 2, 2026, Aurobindo Pharma Limited); the etelcalcetide FDA label on DailyMed (effective March 8, 2026, Amgen, Inc).

What does the cinacalcet label say about etelcalcetide?

Cinacalcet's label (effective April 2, 2026) and its 1 other brand-application label do not name etelcalcetide in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Cinacalcet), Aurobindo Pharma Limited, effective April 2, 2026 (SPL set 200390f2-7dad-4ecc-a086-c29e18525c01), via openFDA; the full label on DailyMed

What does the etelcalcetide label say about cinacalcet?

Etelcalcetide label, warnings and precautions

Patients switching from cinacalcet to PARSABIV should discontinue cinacalcet for at least 7 days prior to initiating PARSABIV [see Dosage and Administration (2.4) ].

Source: FDA drug label (PARSABIV), NDA208325 (Kai Pharms Inc), as published by Amgen, Inc, effective March 8, 2026 (SPL set cd270093-c6a8-4596-a4ab-e6aa0a2c8a0c), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

16Cinacalcet generic labelers
0Etelcalcetide generic labelers
CinacalcetEtelcalcetide
Labeled forn/an/a
Boxed warningNoNo
Pharmacy cost (NADAC)$0.411 per tablet 30 mg tabletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?